SP
ADAP
Syncona Portfolio’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,377,294
| Closed | -$1.09M | – | 3 |
|
|
2023
Q4 | $1.09M | Hold |
1,377,294
| – | – | 0.69% | 4 |
|
|
2023
Q3 | $1.07M | Hold |
1,377,294
| – | – | 1.6% | 4 |
|
|
2023
Q2 | $1.27M | Hold |
1,377,294
| – | – | 1.92% | 4 |
|
|
2023
Q1 | $1.5M | Hold |
1,377,294
| – | – | 2.44% | 4 |
|
|
2022
Q4 | $2.01M | Hold |
1,377,294
| – | – | 3.19% | 4 |
|
|
2022
Q3 | $1.48M | Hold |
1,377,294
| – | – | 2.57% | 4 |
|
|
2022
Q2 | $2.34M | Hold |
1,377,294
| – | – | 3.33% | 4 |
|
|
2022
Q1 | $5.17M | Hold |
1,377,294
| – | – | 4.93% | 4 |
|
|
2021
Q4 | $5.17M | Buy |
+1,377,294
| New | +$5.17M | 4.93% | 4 |
|